Table of Contents

2019-2024 Global mRNA Vaccines & Therapeutics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2014-2024
2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region
2.2 mRNA Vaccines & Therapeutics Segment by Type
2.2.1 Standardization Of Cancer Treatment MRNA Vaccine
2.2.2 Individualized Cancer Treatment MRNA Vaccine
2.2.3 Infectious Disease Treatment MRNA Vaccine
2.2.4 Infection Prevention MRNA Vaccine
2.3 mRNA Vaccines & Therapeutics Consumption by Type
2.3.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2014-2019)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2014-2019)
2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2014-2019)
2.4 mRNA Vaccines & Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Other
2.5 mRNA Vaccines & Therapeutics Consumption by Application
2.5.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2014-2019)
2.5.2 Global mRNA Vaccines & Therapeutics Value and Market Share by Application (2014-2019)
2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2014-2019)

3 Global mRNA Vaccines & Therapeutics by Players
3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Players
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Players (2017-2019)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Players (2017-2019)
3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Players (2017-2019)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2017-2019)
3.3 Global mRNA Vaccines & Therapeutics Sale Price by Players
3.4 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 mRNA Vaccines & Therapeutics by Regions
4.1 mRNA Vaccines & Therapeutics by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Consumption by Regions
4.1.2 Global mRNA Vaccines & Therapeutics Value by Regions
4.2 Americas mRNA Vaccines & Therapeutics Consumption Growth
4.3 APAC mRNA Vaccines & Therapeutics Consumption Growth
4.4 Europe mRNA Vaccines & Therapeutics Consumption Growth
4.5 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Growth

5 Americas
5.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries
5.1.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
5.1.2 Americas mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
5.2 Americas mRNA Vaccines & Therapeutics Consumption by Type
5.3 Americas mRNA Vaccines & Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC mRNA Vaccines & Therapeutics Consumption by Countries
6.1.1 APAC mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
6.1.2 APAC mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
6.2 APAC mRNA Vaccines & Therapeutics Consumption by Type
6.3 APAC mRNA Vaccines & Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe mRNA Vaccines & Therapeutics by Countries
7.1.1 Europe mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
7.1.2 Europe mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
7.2 Europe mRNA Vaccines & Therapeutics Consumption by Type
7.3 Europe mRNA Vaccines & Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Countries
8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Value by Countries (2014-2019)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Type
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 mRNA Vaccines & Therapeutics Distributors
10.3 mRNA Vaccines & Therapeutics Customer

11 Global mRNA Vaccines & Therapeutics Market Forecast
11.1 Global mRNA Vaccines & Therapeutics Consumption Forecast (2019-2024)
11.2 Global mRNA Vaccines & Therapeutics Forecast by Regions
11.2.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2019-2024)
11.2.2 Global mRNA Vaccines & Therapeutics Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global mRNA Vaccines & Therapeutics Forecast by Type
11.8 Global mRNA Vaccines & Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Moderna Therapeutics
12.1.1 Company Details
12.1.2 mRNA Vaccines & Therapeutics Product Offered
12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Moderna Therapeutics News
12.2 CureVac
12.2.1 Company Details
12.2.2 mRNA Vaccines & Therapeutics Product Offered
12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 CureVac News
12.3 Translate Bio
12.3.1 Company Details
12.3.2 mRNA Vaccines & Therapeutics Product Offered
12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Translate Bio News
12.4 BioNTech
12.4.1 Company Details
12.4.2 mRNA Vaccines & Therapeutics Product Offered
12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 BioNTech News
12.5 Sangamo Therapeutics
12.5.1 Company Details
12.5.2 mRNA Vaccines & Therapeutics Product Offered
12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Sangamo Therapeutics News
12.6 Argos Therapeutics
12.6.1 Company Details
12.6.2 mRNA Vaccines & Therapeutics Product Offered
12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Argos Therapeutics News
12.7 In-Cell-Art
12.7.1 Company Details
12.7.2 mRNA Vaccines & Therapeutics Product Offered
12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 In-Cell-Art News
12.8 eTheRNA
12.8.1 Company Details
12.8.2 mRNA Vaccines & Therapeutics Product Offered
12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 eTheRNA News
12.9 Ethris
12.9.1 Company Details
12.9.2 mRNA Vaccines & Therapeutics Product Offered
12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Ethris News
12.10 Tiba Biotechnology
12.10.1 Company Details
12.10.2 mRNA Vaccines & Therapeutics Product Offered
12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Tiba Biotechnology News

13 Research Findings and Conclusion